MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Altimmune, Inc. Common Stock

ALT

#2852
Altimmune, Inc. - Common Stock
2.5 6 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.56
2.63
Year Range
2.55
6.44
Daily Change
-1.92%
Monthly Change
-21.71%
6 month change
-21.23%
Year Change
-34.69%
Previous Close
2.6 1
Open
2.5 9
Low
2.5 6
High
2.6 3
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. Biotechnology
  5. ALT
Open full chart

Financials

Overview Statement Statistics Documents

2005

Quarterly report, Q2 FY2005

2005.09.12
Altimmune, Inc. quarterly report, Q2 FY2005
10-Q
  • 1
  • ...
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37

News

Zacks
NVO LLY ALT MDGL
2026.10.07

Can NVO's Semaglutide Push Create Growth Beyond Cardiometabolic Care?

Benzinga
ALT
2026.09.23

Evercore ISI Group Maintains Outperform on Altimmune, Lowers Price Target to $17

Zacks
ALT UTHR
2026.09.11

Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?

TipRanks
ALT AMD
2026.09.01

3 Under $10 Stocks With 150%+ Upside to Buy in September 2026, According to Analysts - TipRanks.com

Zacks
ALT NVO MDGL
2026.08.19

Is Altimmune Worth Buying as Cash Rises but Execution Risks Linger?

Zacks
ALT NVO LLY
2026.08.19

Altimmune's Phase III MASH Study Puts 2029 Data in Investor Focus

Zacks
KOD ALT ACIU AMRX
2026.08.14

Kodiak's Q2 Loss Wider Than Expected, Pipeline Development in Focus

Zacks
ALT ACIU AMRX LQDA
2026.08.13

ALT's Q2 Loss Narrower Than Expected, Pemvidutide's Studies in Focus

Seeking Alpha
ALT
2026.08.12

Altimmune, Inc. (ALT) Q2 2026 Earnings Call Transcript

Zacks
BLTE ALT AMRX LQDA
2026.08.12

BLTE Stock Rises as FDA Grants Priority Review to Tinlarebant NDA

Zacks
KOD ALT AMRX LQDA
2026.08.11

KOD Begins Late-Stage Study of KSI-501 in Diabetic Macular Edema

Zacks
PBYI ALT LQDA HRMY
2026.08.07

PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stocks
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Subscribe to algo trading news
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd